Home / Medical Devices / Nitric Oxide Therapy Systems Market By Type (Portable Nitric Oxide Therapy Systems, Fixed Nitric Oxide Therapy Systems), By End Users (Hospitals, Homecare Settings, Clinics) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

Nitric Oxide Therapy Systems Market By Type (Portable Nitric Oxide Therapy Systems, Fixed Nitric Oxide Therapy Systems), By End Users (Hospitals, Homecare Settings, Clinics) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

Published: Jan 2018 | Report Code: 58965-01-18

Neonatal pulmonary hypertension occurs due to the abnormalities encountered in the normal circulatory transition which usually occurs after birth in the neonates. It is also considered as a syndrome due to the manifestation such as hypoxemia which is caused due to pulmonary hypertension and shunting of the blood at the ductus arteriosus and foramen ovale. Acute respiratory distress syndrome is an acute condition in which the diagnosis is done by measuring the ration of partial pressure of oxygen in the arteries to the fraction of oxygen in the inspired air is less than 200. Nitric oxide inhalation through the cyclic GMP induces vasodilation and promotes relief in neonate hypertension and acute respiratory distress syndrome.

The types segment includes the portable nitric oxide therapy systems and fixed nitric oxide therapy systems. The end users segment comprises of hospitals, homecare settings and clinics. Market estimation and data forecast for the duration 2016-2026 is taken into consideration for the types and end users segment.

In line with the scope of report the geographic segmentation is given as follows which includes 5 geographical regions including the major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Data forecast and market sizing for the duration 2016-2026 for the geography segment is taken in the scope of report.

Market assessment is an effective tool which give a brief understanding of the existing market trends and competitive landscape is useful in mapping the current business milieu existing in the nitric oxide therapy systems market. Company profiles section exhibits the diverse product range available for the treatment of pulmonary ailments such as neonate pulmonary hypertension and acute respiratory distress syndrome. The market leaders in global nitric oxide therapy systems market are Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals, Praxair, Inc. and Vapotherm.

Nitric Oxide Therapy Systems Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Nitric Oxide Therapy Systems Market Portraiture
2.1.1. Global Nitric Oxide Therapy Systems Market, by Type, 2017
2.1.2. Global Nitric Oxide Therapy Systems Market, by End Users, 2017
2.1.3. Global Nitric Oxide Therapy Systems Market, by Geography, 2017

Chapter 3. Nitric Oxide Therapy Systems Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Nitric Oxide Therapy Systems Market, 2016-2026 (US$ Mn)
3.8. Competitive Landscape: Global Nitric Oxide Therapy Systems Market, by Key Players, 2015-2025 (US$ Mn)

Chapter 4. Global Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.1.1. Comparative Analysis: Global Nitric Oxide Therapy Systems Market, by Type, 2017 Vs. 2026 (Value %)
4.2. Portable Nitric Oxide Therapy Systems
4.3. Fixed Nitric Oxide Therapy Systems

Chapter 5. Global Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
5.1. Overview
5.1.1. Comparative Analysis: Global Nitric Oxide Therapy Systems Market, by End Users, 2017 Vs. 2026 (Value %)
5.2. Hospitals
5.3. Homecare Settings
5.4. Clinics

Chapter 6. Global Nitric Oxide Therapy Systems Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Nitric Oxide Therapy Systems Market Analysis, 2016 – 2026
6.2.1. North America Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
6.2.3. North America Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Nitric Oxide Therapy Systems Market Analysis, 2016 – 2026
6.3.1. Europe Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
6.3.3. Europe Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Nitric Oxide Therapy Systems Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Nitric Oxide Therapy Systems Market Analysis, 2016 – 2026
6.5.1. Latin America Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Nitric Oxide Therapy Systems Market Analysis, 2016 – 2026
6.6.1. MEA Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
6.6.3. MEA Nitric Oxide Therapy Systems Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Bellerophon Therapeutics
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. BOC Healthcare
7.3. Dan Hammer Health Ltd.
7.4. EKU Elektronik GmbH
7.5. GeNO, LLC
7.6. International Biomedical
7.7. SLE
7.8. Mallinckrodt Pharmaceuticals
7.9. Praxair, Inc.
7.10. Vapotherm

List Of Table:

TABLE 1 Global Nitric Oxide Therapy Systems Market Portraiture
TABLE 2 Global Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 4 Global Nitric Oxide Therapy Systems Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 7 North America Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Nitric Oxide Therapy Systems Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Nitric Oxide Therapy Systems Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Nitric Oxide Therapy Systems Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Nitric Oxide Therapy Systems Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Bellerophon Therapeutics: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 21 BOC Healthcare: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 22 Dan Hammer Health Ltd.: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 23 EKU Elektronik GmbH: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 24 GeNO LLC: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 25 International Biomedical: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 26 SLE: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 27 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 28 Praxair, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 29 Vapotherm: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)

List Of Figures :

FIG. 1 Nitric Oxide Therapy Systems: Market Segmentation
FIG. 2 Global Nitric Oxide Therapy Systems Market Share, by Type, 2016 (Value %)
FIG. 3 Global Nitric Oxide Therapy Systems Market, by End Users, 2016 (Value %)
FIG. 4 Global Nitric Oxide Therapy Systems Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Portable Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Fixed Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Hospitals Market for Nitric Oxide Therapy Systems, 2016 – 2026 (US$ Mn)
FIG. 10 Global Homecare Settings Market for Nitric Oxide Therapy Systems, 2016 – 2026 (US$ Mn)
FIG. 11 Global Clinics Market for Nitric Oxide Therapy Systems, 2016 – 2026 (US$ Mn)
FIG. 12 U.S. Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 13 Canada Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 14 U.K. Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 15 Germany Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 16 Rest of Europe Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 17 Japan Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 18 China Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 19 India Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Asia Pacific Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 21 Brazil Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 22 Mexico Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Latin America Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 24 GCC Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Middle East and Africa Nitric Oxide Therapy Systems Market, 2016 – 2026 (US$ Mn)

Based on type, the nitric oxide therapy systems market is categorized into:

  • Portable Nitric Oxide Therapy Systems
  • Fixed Nitric Oxide Therapy Systems

Nitric Oxide Therapy Systems Market

Nitric oxide is generally used in the intensive care units of hospitals for the treatment of adult respiratory distress syndrome (ARDS) and neonatal pulmonary hypertension. The therapeutic role of nitric oxide as a relaxing factor of the smooth muscle endothelium leading to reduction of pulmonary blood pressure and vasodilation of blood vessels was observed decades ago. The mechanism of action of nitric oxide is to relax alveolar smooth muscles by increase in cyclic guanosine monophosphate. Portable nitric oxide therapy system finds tremendous utilization due to its durability and light weight which permits its easy installation in the intensive care units. They are also available as portable analyzers for the screening of primary ciliary dyskinesias. Fixed nitric oxide therapy systems find application in healthcare institutions such as hospitals and ambulatory care settings due to easy fabrication of its auxiliary holding devices with the main gas supply, low cost and versatile in its gas delivery function. The manufacturers spearheading in the production of nitric oxide therapy systems are Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals, Praxair, Inc. and Vapotherm.

Based on end users, the global nitric oxide therapy systems market is categorized into

  • Hospitals
  • Homecare Settings
  • Clinics

Nitric Oxide Therapy Systems Market

The inhalation of nitric oxide for 8 hours at 25 parts per million (ppm) results in nitric oxide toxicity. Manufacturers are constantly striving to design safety monitoring systems to deliver constant flow of nitric oxide in the ventilator circuit of patients.  Side stream analysis features are present in the nitric oxide delivery system to constantly monitor the concentration of Nitrogen dioxide, nitric oxide and oxygen. Recently NuMed Plus, Inc. has made a patent application for clinical inhaled nitric oxide delivery system primarily developed for providing high quality nitric oxide for medical office environment. Hospitals and clinics currently have a consolidated hold in the nitric oxide therapy systems market on account of rising prevalence of neonate pulmonary hypertension and increasing number of pediatric cardiopulmonary bypass surgery being performed. Homecare settings are rapidly using nitric oxide therapy systems for the treatment of acute respiratory distress syndrome in geriatric population. It is also used in combination with oxygen for the treatment of chronic obstructive pulmonary disease in adults.

For the purpose of this study, the global nitric oxide therapy systems market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Nitric Oxide Therapy Systems Market

As per the research findings of National Center for Health Statistics 2015 report, the age related mortality rate of acute respiratory distress syndrome is 5.01 per 100,000 persons in the United States. The mortality rate is higher in Caucasian males compared to the females. Rising prevalence of acute respiratory distress syndrome and presence of well-developed healthcare infrastructure makes North America the market leader in nitric oxide therapy systems. The mounting geriatric population seeking treatment for acute respiratory distress syndrome in homecare settings is huge in Western European region which influences the market growth of nitric oxide therapy systems in Europe. Rising prevalence of neonate pulmonary hypertension cases and competitive market created due to the emergence of local players supplying nitric oxide therapy systems contribute towards the positive market growth of Asia Pacific region.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients